Market Segmentation:
- By Drug Class
- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
- Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
- Protease Inhibitors (PIs)
- Integrase Inhibitors
- Entry/Fusion Inhibitors
- Others (CCR5 Antagonists, Boosting Agents)
- By Drug Combination
- Single-Tablet Regimens (STRs)
- Multi-Tablet Regimens (MTRs)
- Others (Monotherapies)
- By Route of Administration
- Oral
- Parenteral
- By Dosage Form
- Tablets
- Capsules
- Oral Solutions/Syrups
- Injections
- Others (Granules, Powders)
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Government Agencies
- Others (Mail Order Pharmacies)
- By End-User
- Hospitals
- Clinics
- Homecare Settings
- Others (Research Institutes, Pharmaceutical Companies)
- By Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
The current market size of the Anti-retroviral Drug industry is estimated to be USD 28.5 billion as of 2023.
Increasing prevalence of HIV/AIDS globally, Government initiatives and funding for HIV/AIDS treatment programs, Advancements in research and development of new anti-retroviral drugs, Increasing healthcare expenditure and improving access to treatment, Rising adoption of combination therapies and single-tablet regimens, Expansion of treatment guidelines and improved disease management, Growing awareness and efforts to combat HIV/AIDS stigma
High treatment costs and affordability issues, Drug resistance and development of resistant HIV strains, Adverse effects and toxicity associated with certain anti-retroviral drugs, Stringent regulatory requirements for drug approval, Limited access to healthcare facilities in remote and underdeveloped regions, Lack of adherence to treatment regimens, Stigma and discrimination against HIV/AIDS patients
The leading component segment in the Anti-retroviral Drug Market is the Integrase Inhibitors, known for their high efficacy in suppressing viral replication and better resistance profiles.
The major players operating in the Anti-retroviral Drug Market include Gilead Sciences, Inc., ViiV Healthcare, Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc. (Johnson & Johnson), Merck & Co., Inc., AbbVie Inc., Theratechnologies Inc